Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies

2005 ◽  
Vol 15 (5) ◽  
pp. 799-806 ◽  
Author(s):  
L.H. LE ◽  
K.D. SWENERTON ◽  
L. ELIT ◽  
D.M. PROVENCHER ◽  
G.C.E. STUART ◽  
...  
Keyword(s):  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin

2007 ◽  
Vol 61 (4) ◽  
pp. 695-702 ◽  
Author(s):  
Alberto Gabizon ◽  
Rut Isacson ◽  
Ora Rosengarten ◽  
Dina Tzemach ◽  
Hilary Shmeeda ◽  
...  
Keyword(s):  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Cycle Dependence

scholarly journals A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study

BioDrugs ◽  
2021 ◽  
Vol 35 (3) ◽  
pp. 325-336
Author(s):  
Irene Marafini ◽  
Carmine Stolfi ◽  
Edoardo Troncone ◽  
Elisabetta Lolli ◽  
Sara Onali ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Phase Ii ◽  
Induction Therapy ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

scholarly journals FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLC

2018 ◽  
Vol 13 (11) ◽  
pp. 1733-1742 ◽  
Author(s):  
David R. Spigel ◽  
Jamie E. Chaft ◽  
Scott Gettinger ◽  
Bo H. Chao ◽  
Luc Dirix ◽  
...  
Keyword(s):  
Phase Ii ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Biomarker Analysis
Sign in / Sign up

Export Citation Format

Share Document